276 related articles for article (PubMed ID: 7907855)
21. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.
Genelhu MC; Gobbi H; Soares FA; Campos AH; Ribeiro CA; Cassali GD
Oral Oncol; 2006 Feb; 42(2):154-60. PubMed ID: 16256413
[TBL] [Abstract][Full Text] [Related]
23. Aneuploidy in salivary gland adenomas.
Atula T; Grénman R; Laippala P; Klemi PJ
Eur Arch Otorhinolaryngol; 1995; 252(7):395-400. PubMed ID: 8562033
[TBL] [Abstract][Full Text] [Related]
24. [Malignant pleomorphic adenoma of the salivary gland: a clinicopathological and immunohistochemical study].
Ji XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Nov; 28(6):353-5, 384. PubMed ID: 8033646
[TBL] [Abstract][Full Text] [Related]
25. [Pleomorphic adenoma of the salivary glands. Impact of the myxoid component on the prognosis].
Goudot P; Auriol M; Chomette G; Vaillant JM; Guilbert F
Rev Stomatol Chir Maxillofac; 1989; 90(2):119-22. PubMed ID: 2471255
[TBL] [Abstract][Full Text] [Related]
26. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
27. The immunohistochemical profile of luminal epithelial neoplastic component from pleomorphic adenomas of salivary glands.
Margaritescu C; Florescu M; Raica M; Simionescu C; Mogoanta L; Preda E
Rom J Morphol Embryol; 1999-2004; 45():97-118. PubMed ID: 15847384
[TBL] [Abstract][Full Text] [Related]
28. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
Wang J; Dong F; Wang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
[TBL] [Abstract][Full Text] [Related]
29. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
Suzuki S; Tsuchiya A; Hara K; Abe R
Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
[TBL] [Abstract][Full Text] [Related]
30. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
33. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
34. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
35. Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations.
Gedlicka C; Item CB; Wögerbauer M; Martinek H; Heiduschka G; Erovic BM; Ch Grasl M; Thurnher D
J Surg Oncol; 2010 Feb; 101(2):127-30. PubMed ID: 19950209
[TBL] [Abstract][Full Text] [Related]
36. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
37. Primary pleomorphic adenoma of the external ear canal. Report of a case and literature review.
Markou K; Karasmanis I; Vlachtsis K; Petridis D; Nikolaou A; Vital V
Am J Otolaryngol; 2008; 29(2):142-6. PubMed ID: 18314029
[TBL] [Abstract][Full Text] [Related]
38. Nuclear DNA in salivary gland tumors. I. Warthin tumors, benign mixed tumors, and mucoepidermoid carcinomas.
Kino I; Richart RM; Lattes R
Arch Pathol; 1973 Apr; 95(4):245-51. PubMed ID: 4348724
[No Abstract] [Full Text] [Related]
39. [DNA ploidy and proliferative activity in salivary gland tumours].
Driemel O; Kraft K; Hemmer J
Mund Kiefer Gesichtschir; 2007 Aug; 11(3):139-44. PubMed ID: 17505845
[TBL] [Abstract][Full Text] [Related]
40. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium.
Savera AT; Gown AM; Zarbo RJ
Mod Pathol; 1997 Nov; 10(11):1093-100. PubMed ID: 9388059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
